Patient Education in Pregnant Women With Asthma

Patient Education: Asthma and Pregnancy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05459012

Acronym

TAPAGE

Enrollment

Registered

2022-07-14

Start date

2022-09-19

Completion date

2023-10-31

Last updated

2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Pregnancy may impact treatment adherence in women with asthma. This is a major risk factor for asthma exacerbation, which may have an important impact for both women and the babies. This study aims to evaluate the impact of a targeted patient education action tailored for pregnant women with asthma.

Interventions

OTHERfollow-up

Questionnaire of Quality of life

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult pregnant women with asthma

Exclusion criteria

* women not able to speak and/or read French language * women protected by the law

Design outcomes

Primary

Measure	Time frame	Description
Change from Asthma quality of life between two periods : before intervention and 3 month after the intervention	before and 3 month after the intervention	The physician gives Asthma quality of life questionnaire (AQLQ) before intervention and 3 month after the intervention

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026